The January of Diabetes Care, ( vol 28: pp 96-101.) carries a study by Dr. Sima which evaluated two studies involving over 1200 patients with diabetic neuropathy. Analysis indicated significant improvement, both at the 6 month and 1 year mark using 1000 mgs of Acetyl-L-Carnitine.
People who had been diagnosed with diabetes for the shortest length of time not only experienced the highest level of pain relief, but also showed improvement in nerve structure and reactions.
The researchers said the results suggested that optimal results may be obtained by starting this therapy as early as possible in the course of the disease.
